The bank upgraded the dialysis service provider to buy from hold.
Get this delivered to your inbox, and more info about our products and services.
BofA analysts are bullish on this German medtech name ahead of its full-year earnings report.
The bank pointed to recent M&A success as a catalyst for the stock.
The bank upgraded shares to buy from hold and raised its price target to the highest on the Street.
The bank believes gave a boost to the company following its earnings report that delivered strong guidance for 2026.
RBC Capital Markets predicts that utility stock Evergy could rise 19% from here.
David Keller breaks down the technicals on this biotech giant.
